REQUEST A DEMO
Total
USD $0.00
Search more companies

Naturewortt C.L. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Naturewortt C.L. Profile Updated: April 07, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Naturewortt C.L. is a company in Ecuador, with a head office in Quito. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on February 03, 2016. Naturewortt C.L. currently employs 4 (2021) people. There was a net sales revenue increase of 22.57% reported in Naturewortt C.L.’s latest financial highlights for 2022. There was a total negative growth of 28.79% in Naturewortt C.L.’s total assets over the same period. The net profit margin of Naturewortt C.L. increased by 48.58% in 2022.

Headquarters
de las Anonas E11-74
Quito; Pichincha;

Contact Details: Purchase the Naturewortt C.L. report to view the information.

Basic Information
Total Employees:
Purchase the Naturewortt C.L. report to view the information.
Outstanding Shares:
Purchase the Naturewortt C.L. report to view the information.
Registered Capital:
Purchase the Naturewortt C.L. report to view the information.
Incorporation Date:
February 03, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Naturewortt C.L. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
22.57%
Total operating revenue
50%
Operating profit (EBIT)
50.87%
EBITDA
51.79%
Net Profit (Loss) for the Period
50.82%
Total assets
-28.79%
Total equity
-10.29%
Operating Profit Margin (ROS)
48.51%
Net Profit Margin
48.58%
Return on Equity (ROE)
-11.6%
Quick Ratio
-84.66%
Cash Ratio
-7.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?